Trial site
Careggi University Hospital
- 204running trials
- 126closed trials
The trials here
What the 332 trials at this site are about, from their registry records.
- Conditions
- Lung cancer49 trials
- Myeloproliferative neoplasms18 trials
- Colorectal cancer13 trials
- Myelodysplastic syndromes12 trials
- Haemophilia11 trials
- Acute myeloid leukaemia10 trials
- Chronic lymphocytic leukaemia10 trials
- Idiopathic pulmonary fibrosis10 trials
- Multiple myeloma10 trials
- Head and neck cancer9 trials
- Hypertrophic cardiomyopathy9 trials
- Multiple sclerosis9 trials
- and 69 more
- Phase
- Phase 3176 trials
- Phase 293 trials
- Phase 2/316 trials
- Phase 416 trials
- Phase 1/214 trials
- Phase 16 trials
- Status
- Completed123 trials
- Active, not recruiting117 trials
- Recruiting75 trials
- Not yet recruiting11 trials
- Suspended2 trials
- Withdrawn2 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- AstraZeneca23 trials
- Merck Sharp & Dohme LLC20 trials
- Hoffmann-La Roche10 trials
- GlaxoSmithKline8 trials
- Gruppo Italiano Malattie EMatologiche dell'Adulto8 trials
- and 163 more
Running trials
Recruiting
Recruiting
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
Recruiting
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Recruiting
PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
Recruiting
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Active, not recruiting
Recruiting
An extension study for patients previously enrolled in studies with pelabresib
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Showing 50 of 204.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer16 recruiting
- Myeloproliferative neoplasms7 recruiting
- Colorectal cancer6 recruiting
- Chronic lymphocytic leukaemia5 recruiting
- Head and neck cancer5 recruiting
- Coronary artery disease3 recruiting
- Haemophilia3 recruiting
- Acute myeloid leukaemia2 recruiting
- Amyloidosis2 recruiting
- Atrial fibrillation2 recruiting
- Bladder cancer2 recruiting
- Crohn's disease2 recruiting
- Follicular lymphoma2 recruiting
- Kidney cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Macular degeneration2 recruiting
- Multiple myeloma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Ovarian cancer2 recruiting
- Prostate cancer2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Chronic kidney disease1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Hodgkin lymphoma1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- IgA nephropathy1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Mantle cell lymphoma1 recruiting
- Meningioma1 recruiting
- Mesothelioma1 recruiting
- Multiple sclerosis1 recruiting
- Myocarditis1 recruiting
- Osteoarthritis1 recruiting
- Pancreatic cancer1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thalassaemia1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Recruiting
Completed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Completed
Completed
Completed
Active, not recruiting
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
Completed
Completed
Completed
Completed
Completed
Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Effect of the Probiotic SF68® on Body Composition and Low-to-moderate Cardiovascular Risk
Completed
Completed
Terminated
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
Completed
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy
Completed
Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer
Completed
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Showing 50 of 126.
Site data: ClinicalTrials.govUpdated 18 Nov 2026